Track topics on Twitter Track topics that are important to you
In what seems like some consolation for Daiichi Sankyo after its disastrous acquisition of Ranbaxy Laboratories and subsequent divestment of the Indian company, arbitration proceedings in Singapore ag...
An arbitration panel found the former controlling stakeholders of Ranbaxy concealed information when they sold the firm to Daiichi Sankyo.
The two former owners of India's Ranbaxy Laboratories have been ordered to pay $385 million to Daiichi Sankyo Co., the Japanese pharmaceutical company that bought the drugmaker in 2008.
The former owners of Indian drugmaker Ranbaxy have been ordered to pay Daiichi Sankyo $385m for concealing quality problems across its manufacturing network before selling the business.
Incriminating details in an arbitration order against the former Ranbaxy top brass led by the Singh brothers has put the...
Around 500 Sun Pharma medical representatives, previously employed by Ranbaxy prior to the acquisition by Sun Pharma, are planning a nationwide strike in India to protest unpaid salaries, travel expen...
MUMBAI (Reuters) - The former owners of Indian drugmaker Ranbaxy Laboratories have been ordered by an arbitration court to pay damages worth 25.63 billion rupees ($385 million) to Japan's Daiichi Sank...
* Says Daiichi Sankyo received a final award in the arbitration that it filed with the International Court of Arbitration of the International Chamber of Commerce in November 2012 against the former s...
Few data are present in the literature on the relationship between atorvastatin use and acute pancreatitis. The aim of this study was to explore this issue in Taiwan.Using representative claims data e...
Atorvastatin is a cholesterol-lowering statin that has been shown to exert several pleiotropic effects in the nervous system as a neuroprotective and antidepressant-like agent. Antidepressant-like eff...
The use of atorvastatin is rapidly increasing among statins since the introduction of generics. However, only limited data are available on its current use and the effectiveness outside of randomised ...
This study aimed to examine the effects of amlodipine and atorvastatin alone or in combination on the regulation of inflammatory cytokines and the underlying mechanisms in elderly spontaneously hypert...
Publicly-funded atorvastatin required prior approval until September 2010 whereas simvastatin did not. Our aim was to examine if overall statin dispensing and atorvastatin dispensing among patients ho...